354 related articles for article (PubMed ID: 36295656)
1. Non-Transfusion-Dependent Thalassemia: A Panoramic Review.
Shash H
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295656
[TBL] [Abstract][Full Text] [Related]
2. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management.
Vichinsky E
Curr Med Res Opin; 2016; 32(1):191-204. PubMed ID: 26479125
[TBL] [Abstract][Full Text] [Related]
3. Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.
Sleiman J; Tarhini A; Bou-Fakhredin R; Saliba AN; Cappellini MD; Taher AT
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316681
[TBL] [Abstract][Full Text] [Related]
4. Morbidities in non-transfusion-dependent thalassemia.
Saliba AN; Taher AT
Ann N Y Acad Sci; 2016 Mar; 1368(1):82-94. PubMed ID: 27186941
[TBL] [Abstract][Full Text] [Related]
5. Iron overload in thalassemia: different organs at different rates.
Taher AT; Saliba AN
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):265-271. PubMed ID: 29222265
[TBL] [Abstract][Full Text] [Related]
6. Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.
Taher AT; Temraz S; Cappellini MD
Expert Rev Hematol; 2013 Oct; 6(5):495-509. PubMed ID: 24083402
[TBL] [Abstract][Full Text] [Related]
7. How I treat non-transfusion-dependent β-thalassemia.
Saliba AN; Musallam KM; Taher AT
Blood; 2023 Sep; 142(11):949-960. PubMed ID: 37478396
[TBL] [Abstract][Full Text] [Related]
8. Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): a status quo.
Taher AT; Musallam KM; Viprakasit V; Porter JB; Cappellini MD
Blood Cells Mol Dis; 2014; 52(2-3):88-90. PubMed ID: 24041597
[No Abstract] [Full Text] [Related]
9. New therapeutic targets in transfusion-dependent and -independent thalassemia.
Cappellini MD; Motta I
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
[TBL] [Abstract][Full Text] [Related]
10. Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes.
Ricchi P; Marsella M
Drug Des Devel Ther; 2015; 9():6475-82. PubMed ID: 26719673
[TBL] [Abstract][Full Text] [Related]
11. Thalassemia Intermedia: Chelator or Not?
Lee YC; Yen CT; Lee YL; Chen RJ
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077584
[TBL] [Abstract][Full Text] [Related]
12. Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.
Bou-Fakhredin R; Bazarbachi AH; Chaya B; Sleiman J; Cappellini MD; Taher AT
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261151
[TBL] [Abstract][Full Text] [Related]
13. Iron Chelation Therapy as a Modality of Management.
Aydinok Y
Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
[TBL] [Abstract][Full Text] [Related]
14. Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia.
Shirley M; Plosker GL
Drugs; 2014 Jun; 74(9):1017-27. PubMed ID: 24919862
[TBL] [Abstract][Full Text] [Related]
15. Non-transfusion-dependent thalassemias.
Musallam KM; Rivella S; Vichinsky E; Rachmilewitz EA
Haematologica; 2013 Jun; 98(6):833-44. PubMed ID: 23729725
[TBL] [Abstract][Full Text] [Related]
16. [Current management of thalassemia intermedia].
Thuret I
Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
[TBL] [Abstract][Full Text] [Related]
17. Treating iron overload in patients with non-transfusion-dependent thalassemia.
Taher AT; Viprakasit V; Musallam KM; Cappellini MD
Am J Hematol; 2013 May; 88(5):409-15. PubMed ID: 23475638
[TBL] [Abstract][Full Text] [Related]
18. Non-transfusion Dependent Thalassemias: A Developing Country Perspective.
Mukherjee S; Das RR; Raghuwanshi B
Curr Pediatr Rev; 2015; 11(2):87-97. PubMed ID: 26133180
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Transfusion and Iron Chelation in Thalassemias.
Porter JB; Garbowski MW
Hematol Oncol Clin North Am; 2018 Apr; 32(2):247-259. PubMed ID: 29458730
[TBL] [Abstract][Full Text] [Related]
20. Increasing prevalence of thalassemia in America: Implications for primary care.
Sayani FA; Kwiatkowski JL
Ann Med; 2015; 47(7):592-604. PubMed ID: 26541064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
